As AI advances genomic analyses, the potential for misuse grows, amplifying risks of discrimination and exploitation that could span generations. 23andMe’s struggles demonstrate that the ...

While 23andMe’s privacy statement has changed since ... publicized 23andMe data to try to find a match. And who knows what AI systems will be able to learn based on our DNA, and all the ways ...

23andMe’s shares have traded below the $1 Nasdaq ... as those interested in its consumer business or its potential for AI. A ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

It remains unknown how many patients are affected by the incident. The Qilin ransomware group claims to have leaked 400 ...

23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an earnings call in February last year. She said the biotech company, which offers direct-to-consumer genetic testing ...

From cloud chaos to clarity.” In this episode, AT&T’s Erian Laperi, Kristina Sutton, and Dan Wagner discuss transforming one ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola ...

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, and the non-profit Sickle Cell 101, have joined forces to expand awareness of people’s sickle ...

23andMe's stock plummeted after a 2023 data breach exposed millions of customer accounts. The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its ...

23andMe has been exploring a possible sale of its telehealth business, Business Insider has learned. The struggling health company bought the virtual-care startup Lemonaid in 2021 for $400 million ...